Skip to content

Protecting against Respiratory tract Infections through human Milk Analysis.

Protecting against Respiratory tract Infections through human Milk Analysis. - PRIMA

Status
Unknown
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON48053
Enrollment
1000
Registered
2020-02-19
Start date
Unknown
Completion date
Unknown
Last updated
2024-04-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

pneumonia Respiratory tract infection

Interventions

None listed

Sponsors

Universitair Medisch Centrum Utrecht
Lead Sponsor

Eligibility

Age
2 Years to 99 Years

Inclusion criteria

Inclusion criteria: All healthy childen (and their parents) born at a minimal gestational age of 32 weeks.

Exclusion criteria

Exclusion criteria: Exclusion criteria concerning the child: - Congenital heart defect. - Congenital lung disorder or other severe organ dysfunction. - (extreme) prematurtity (B1 CEFR level).

Design outcomes

Primary

MeasureTime frame
The amount of medically attended respiratory tract infections during the first year of life.

Secondary

MeasureTime frame
1. The amount of medically attended respiratory tract infections for every quarter of a year during the first year of life. 2. The amount of prescribed antibiotic treatments for respiratory tract infections during the first year of life. 3. The total amount of respiratory tract infection periods during every quarter of a year for the first year of life. 4. Food allergies diagnosed by a physician during the first year of life. 5. Inhalation allergies diagnosed by a physician during the first year of life. 6. Eczema diagnosed by a physician during the first year of life.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)